EDGAR Filing Documents for 0001193125-17-040060

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001193125-17-040060

Filing Date

2017-02-13

Accepted

2017-02-13 13:47:02

Documents

Group Members

ANSBERT GADICKEDENNIS HENNERKURT WHEELERLUKE EVNINMPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLCMPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES III GP, L.P.MPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND, L.P.MPM BIOVENTURES III-QP,

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	d274587dsc13g.htm	SC 13G	207367
2	EX-99.A	d274587dex99a.htm	EX-99.A	31170
	Complete submission text file	0001193125-17-040060.txt		240707

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116

Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200

MPM BIOVENTURES III L.P. (Filed by) CIK: 0001173408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 949 FELL STREET BALTIMORE MD 21231

Business Address 949 FELL STREET BALTIMORE MD 21231 410-387-4000

VACCINOGEN INC (Subject) CIK: 0001453001 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: SC 13G | Act: 34 | File No.: 005-87974 | Film No.: 17597899
SIC: 2834 Pharmaceutical Preparations